相关实验视频

Updated: May 10, 2026

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Published on: November 1, 2019

对阿尔茨海默病进展的个性化建模从EEG记录中估计了神经退行症的严重程度

Lorenzo Gaetano Amato^1,2, Alberto Arturo Vergani^1,2, Michael Lassi^1,2

¹The BioRobotics Institute Sant'Anna School of Advanced Studies Pisa Italy.

Alzheimer's & dementia (Amsterdam, Netherlands)

|February 19, 2024

概括

使用脑电图 (EEG) 的新型个性化皮质模型可以在早期阶段准确识别阿尔茨海默病 (AD) 标志物. 这种非侵入性方法有助于对轻度认知障碍进行分类,并预测疾病的进展.

科学领域:

神经科学是一个神经科学.
生物医学工程生物医学工程

背景情况:

早期识别阿尔茨海默病 (AD) 对于有效的治疗干预至关重要.
在AD中,皮层结构变化很难用传统方法检测到.

研究的目的:

开发和验证一个个性化的皮质模型,用EEG检测AD相关的神经退行.
评估模型在区分健康对照 (HC),主观认知衰退 (SCD) 和轻度认知障碍 (MCI) 群体之间的有效性.

主要方法:

创建了一个新的AD神经退行模型,结合了局部动态减缓和全球连接性退化.
休息状态EEG数据从17名HC,58名SCD和44名MCI参与者收集.
用单个EEG记录来估计神经退行模式参数.

主要成果:

个性化模型在区分HC和MCI方面获得了0.95 F1分,明显优于标准EEG分析 (0.75 F1分).
该模型确定了AD生物标志物具有SCD患者的0.87回忆,而标准EEG的0.50.
该模型准确地预测了三分之三的SCD受试者在一年内过渡到MCI.

结论:

基于EEG的个性化模型可以有效地支持MCI分类和评估AD病理.
这种非侵入性方法为估计认知衰退进展风险提供了一个有希望的工具.
经济和可访问的EEG记录可以用于先进的AD诊断.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.计算模型是计算模型.计算神经科学是一种计算神经科学.这是一个EEGEEGEEGEEGEEGEEGEEG.新型生物标志物新型生物标志物

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

相关概念视频

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...